Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Reexamination Certificate
2004-09-30
2008-11-18
Barnhart, Lora E (Department: 1651)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
C604S508000, C604S509000, C604S510000, C604S522000, C004S325000
Reexamination Certificate
active
07452532
ABSTRACT:
A method for repairing tissue of a selected organ from among heart, brain, liver, pancreas, kidney, glands, and muscles in a patient's body. Adult stem cells that have the capability to repair tissue of the selected organ are recovered by harvesting from the patient's body. The harvested stem cells are then intraluminally applied through a designated natural body vessel. During the time the stem cells are being applied to the targeted tissue downstream, the designated vessel or duct is selectively occluded to increase concentration and pressure of the applied adult stem cells by the vessel.
REFERENCES:
Barbash et al., “Systematic Delivery of Bone Marrow-Derived from Mesenchymal Stem Cells etc.,” Circulation, 108:863-68, 2003.
Orlic et al., “Bone Marrow Cells Regenerate Infracted Myocardium,” Letter to Nature, undated.
Sussman, “Heart and Bones,” Letters to Nature 410:640-641, 2001.
Rangappa et al., “Transformation of Adult Mesenchymal Stem Cells Isolated from the Fatty Tissue etc.,” Ann Thorac. Surg. 75:775-79, 2003.
National Institutes of Health (NIH), “Rebuilding the Nervous System with Stem Cells,” NIH web page (http://stemcells.nih.gov).
NIH, “Bone Marrow Stem Cells Useful,” 2003.
Study re “Stem Cells Hold Promise for Treating Disease,” Journal of Tissue Engineering, Jan. 26, 2002.
Blau et al., “The Evolving Concept of a Stem Cell: Entity or Function?,” Cell 105:829-41, Jun. 29, 2001.
“Pancreas Islet Cells can be Injected Through the Hepatic Vein of the Liver,” article from Internal Medicine News, Jul. 1, 2003.
Bonner-Weir et al., Pancreatic Stem Cells, J Pathol, 107:519-26, 2002.
Reubinoff B et al., “Neural Progenitors from Human Embryonic Stem Cells,” Nature Biotechnology, 19:1134-40, 2001.
Kopen G et al., “Marrow Stromal Cells Migrate Throughout Forebrain and Cerebellum, and they Differentiate into Astrocytes After Injection into Neonatal Mouse Brains,” Proc. Natl. Acad. Sci. USA. 96:10711-16, 1999.
Abraham A et al., “Human Pancreatic Islet-Derived Progenitor Cell Engraftment in Immunocompetent Mice,” American Journal of Pathology, 164:817-30, 2004.
Masuya M et al., “Hematopoietic Origin of Glomerular Mesangial Cells” Blood, 101, 6:2215-18, 2003.
Rosenthal N, “Prometheus's Vulture and the Stem-Cell Promise” N. Engl. J. Med. 349:267-74, 2003.
Kinnaird T et al., “Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine Mechanisms Circulation,” 109:1543-49, 2004.
Stedman's Medical Dictionary, 27thEdition, duct, 2003.
Olanow, “Surgical Therapy for Parkinson's Disease,” Eur. J. Neurol. 9, 3:31-39, 2002.
Ostenfeld et al., “Recent Advances in Stem Cell Neurobiology,” Advances and Technical Standards in Neurosurgery, 28:3-89, 2003.
Anglani et al., “In Search of Renal Stem Cells,” G. Ital. Nefrol 19, 6:607-616, 2002.
Gompe, “Liver Repopulation for the Treatment of Metabolic Diseases,” J. Inherited Metabolic Disease 24, 2:231-44, 2001.
Schomig A. et al., “Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction,” N Engl J Med 2000; 343:385-391.
Braunwald E. et al., “Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival: should the paradigm be expanded?,” Circulation 1989; 79:441-4.
Goldstein M. A. et al., “DNA synthesis and mitosis in well-differentiated mammalian cardiocytes,” Science 1974; 183:212-3.
Claycomb W. C. et al., “Culture of the terminally differentiated adult cardiac muscle cell: A light and scanning electron microscope study,” Dev Biol 1980;80:466-482.
Delcarpio J. B. et al., “Morphological characterization of cardiomyocytes isolated from a trans-plantable cardiac tumor derived from transgenic mouse atria (AT-1 cells),” Circ Res 1991:69(6):1591-1600.
Lanson Jr. N. A. et al., “Gene expression and atrial natriuretic factor processing and secretion in cultured AT-1 cardiac myocytes,” Circulation 1992; 85(5):1835-1841.
Kline R. P. et al., “Spontaneous activity in transgenic mouse heart: Comparison of primary atrial tumor with cultured AT-1 atrial myocytes,” J Cardiovasc Electrophysiol 1993; 4(6):642-660.
Borisov A. B. et al., “Proliferative potential and differentiated characteristics of cultured cardiac muscle cells expressing the SV 40 T oncogene,” Card Growth Reg 1995; 752:80-91.
Claycomb W. C. et al., “HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte,” Proc Natl Acad Sci USA 1998; 95:2979-84.
Watanabe E. et al., “Cardiomyocyte transplantation in a porcine myocardial infarction model,” Cell Transplant 1998; 7(3):239-246.
Watanabe E. et al., “Effect of basic fibroblast growth factor on angiogenesis in the infarcted porcine heart,” Basic Res Cardiol 1998; 93:30-7.
Lee J. S. et al., “Gene therapy for therapeutic myocardial angiogenesis: A promising synthesis of two emerging technologies,” Nat Med 1998; 4(6):739-42.
Kocher A. A. et al., “Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces re-modeling and improves cardiac function,” Nat Med 2001; 7(4)430-6.
Taylor D. A. et al., “Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation,” Nat Med 1998; 4(8):929-33.
Scorsin M. et al., “Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular funtion,” J Thorac Cardiovasc Surg 2000; 119:1169-75.
Galli R et al., “Skeletal myogenic potential of human and mouse neural stem cell,” Nat Neurosci 2000;3:986-991.
Jackson K. A. et al., “Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells,” J Clin Invest 2001;107(11):11395-402.
Prockop D. J. et al., “Marrow stromal cells for non hematopoetic stem tissues,” Science 1997; 276:71-74.
Orlic D. et al., “Bone marrow cells regenerate infarcted myocardium,” Nature 2001; 410:701-5.
Zuk P. A. et al., “Multilineage cells from human adipose tissue: Implications for cell-based therapies,” Tiss Engin 2001; 7(2):211-28.
Kehat I. et al., “Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes,” J Clin Invest 2001; 108:407-14.
Klug M. G. et al., “Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts,” J Clin Invest 1996; 98(1):216-24.
Thomson J. A. et al., “Isolation of a primate embryonic stem cell,” Proc Natl. Acad Sci USA 1995; 92:7844-48.
Makino S. et al., “Cardiomyocytes can be generated from marrow stromal cells in vitro,” J Clin Invest 1999; 103:697-705.
Barnhart Lora E
Hanley Flight & Zimmerman LLC
SciCoTec GmbH
LandOfFree
Transluminal application of adult stem cells for body organ... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transluminal application of adult stem cells for body organ..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transluminal application of adult stem cells for body organ... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4049959